Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

124.39
Delayed Data
As of 3:59pm ET
 +0.48 / +0.39%
Today’s Change
68.03
Today|||52-Week Range
153.15
+24.06%
Year-to-Date

Today’s Trading

Previous close123.91
Today’s open124.70
Day’s range124.02 - 124.91
Volume1,174,296
Average volume (3 months)2,261,173
Market cap$25.4B
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-141.06%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+46.70%
P/E ratio230.4
Price/Sales17.60
Price/Book55.79

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+1.01+0.84%
ZTSZoetis Inc+0.13+0.24%
BAXBaxter International...-0.24-0.45%
VRTXVertex Pharmaceutica...-0.39-0.33%
Data as of 4:03pm ET, 04/25/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.91
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts


Search for Jobs